Manufacturing, Parenterals and Injectables

Fujifilm Corporation to Invest $928 Million into Fujifilm Diosynth Biotechnologies’ Denmark Site

June 10, 2020

The investment will increase production lines for bulk drug substance and will add a fill/finish production line to the site.

SiO2 Scales Up Container Technology for COVID-19 Vaccines and Treatments

June 08, 2020

SiO2 Materials Science has received $143 million from the US government to accelerate capacity scale-up of its advanced primary packaging platform.

Stevanato’s New Boston Technology Center to Open in September

June 04, 2020

The center will offer expertise in fill-finish optimization and analytical testing.

Ajinomoto Bio-Pharma Services, Humanigen in Manufacturing Agreement for COVID-19 Biologic

June 01, 2020

The companies have entered into a manufacturing agreement for the fill finish supply of lenzilumab for the potential treatment of COVID-19.

PharmTech Sponsored eBooks

Complications in Process Simulation Execution

June 01, 2020

Regulators have exaggerated expectations for simulated media fills.

BARDA Funds US-based Drug Manufacturing Initiative

May 19, 2020

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.

Wavelength Pharmaceuticals Expands Supplies of Drug Ingredients for Managing COVID-19 and Adds API CDMO Services

April 23, 2020

Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.

Addressing Drug Shortages

April 02, 2020

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.

FDA and EMA Accept Biologics Application for Novartis Multiple Sclerosis Cell Therapy

February 27, 2020

If approved, the therapy may become the first-choice treatment for relapsing multiple sclerosis patients and will be the first B-cell therapy that can be self-administered using an autoinjector pen.

Schott to Present New Syringe Format at Pharmapack 2020

February 06, 2020

The company will showcase the syriQ BioPure syringe in a 2.25-mL format for autoinjectors at Pharmapack in Paris, France from Feb. 5¬¬–6, 2020.